00000nam 2200000za 4500 9.847672 CaOODSP 20221107153507 cr ||||||||||| 171123s2018 onc o f000 0 eng d 9780660239897 9780660239903 CaOODSP eng n-cn--- NR16-179/2017E-PDF HEK293 expression platform (L-10894/11266/11565) [electronic resource]. [Ottawa] : National Research Council Canada, [2018] [1] p. Issued also in French under title: Plateforme d’expression HEK293 (L-10894/11266/11565). Caption title. "December 2017." “There is an increasing demand for biopharmaceuticals such as vaccines, humanized monoclonal antibodies, and gene therapy products produced from animal cell culture processes. The NRC’s HEK293 expression system enables the high yield production of viral vector and post-translationally modified recombinant proteins through suspension-growing, serum-free adapted cell lines. It provides an optimized, chemically defined formulation for serum-free suspension culture of this cell line. The cell line can be used in combination with the cumate and coumermycin switches, which enable producers to turn on the expression of a given protein only when needed”--Highlights. Issued also in print format. Recombinant proteins Cultures and culture media HEK293 Cells National Research Council Canada. Plateforme d’expression HEK293 (L-10894/11266/11565) (CaOODSP)9.847676 HEK293 expression platform (CaOODSP)9.847673 PDF 119 KB https://publications.gc.ca/collections/collection_2018/cnrc-nrc/NR16-179-2017-eng.pdf